Free Trial

Kaleido Biosciences (KLDO) Competitors

Kaleido Biosciences logo

KLDO vs. PRST, ELYS, GROM, ICCT, KBNT, ALFIW, APCXW, ARBEW, AOGOW, and AOGOU

Should you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Presto Automation (PRST), Elys BMG Group (ELYS), Grom Social Enterprises (GROM), iCoreConnect (ICCT), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), and Arogo Capital Acquisition (AOGOU). These companies are all part of the "computer software" industry.

Kaleido Biosciences vs. Its Competitors

Presto Automation (NASDAQ:PRST) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap computer software companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
Presto AutomationN/A N/A N/A
Kaleido Biosciences N/A N/A N/A

Presto Automation has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500.

20.9% of Presto Automation shares are owned by institutional investors. Comparatively, 81.6% of Kaleido Biosciences shares are owned by institutional investors. 10.0% of Presto Automation shares are owned by company insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Presto Automation has higher revenue and earnings than Kaleido Biosciences. Presto Automation is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Presto Automation$19.05M0.00-$34.48M-$1.230.00
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A

In the previous week, Presto Automation had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for Presto Automation and 0 mentions for Kaleido Biosciences. Presto Automation's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score.

Company Overall Sentiment
Presto Automation Neutral
Kaleido Biosciences Neutral

Summary

Presto Automation beats Kaleido Biosciences on 6 of the 8 factors compared between the two stocks.

Get Kaleido Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KLDO vs. The Competition

MetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market Cap$6.39M$149.76M$5.75B$9.85B
Dividend YieldN/A3.78%6.67%4.51%
P/E Ratio0.0043.3078.4326.42
Price / SalesN/A4,952.93546.94119.09
Price / CashN/A13.1937.0558.92
Price / BookN/A76.1510.916.06
Net Income-$95.48M-$90.99M$3.29B$266.28M

Kaleido Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KLDO
Kaleido Biosciences
N/AN/AN/AN/A$6.39M$1.10M0.0080News Coverage
PRST
Presto Automation
0.0862 of 5 stars
$0.00
-50.0%
N/A-98.8%$10K$19.05M0.004Upcoming Earnings
Gap Down
ELYS
Elys BMG Group
N/A$0.00
-99.7%
N/A-33.3%$8K$43.86M0.0090News Coverage
Options Volume
Gap Down
GROM
Grom Social Enterprises
0.229 of 5 stars
$0.00
flat
N/A-98.6%$4K$3.72M0.00450
ICCT
iCoreConnect
1.7375 of 5 stars
$0.00
+300.0%
N/A-100.0%$4K$11.05M0.0041Short Interest ↓
Gap Up
KBNT
Kubient
N/AN/AN/AN/A$1K$1.17M0.0040
ALFIW
Alfi
N/AN/AN/AN/A$0.00$200.68K0.0040
APCXW
AppTech Payments
N/A$0.15
flat
N/AN/A$0.00$276K0.0020
ARBEW
Arbe Robotics
N/A$0.20
-9.1%
N/A-0.1%$0.00$536K0.00120Gap Up
AOGOW
Arogo Capital Acquisition
N/A$0.03
flat
N/AN/A$0.00N/A0.00N/A
AOGOU
Arogo Capital Acquisition
N/A$8.50
flat
N/AN/A$0.00N/A0.00N/A

Related Companies and Tools


This page (NASDAQ:KLDO) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners